FindTrial
Sign In

THE ROLE OF CIRCULATING TUMOUR CELLS AS EARLY PREDICTORS OF TUMOUR RECURRENCE AFTER SURGERY FOR HEPATOCELLULAR CARCINOMA

CIRCULATING TUMOR CELLS AS PREDICTORS OF RECURRENCE AFTER TRANSPLANT FOR HEPATOCELLULAR CARCINOMA

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/04/051771
Enrollment
50
Registered
2023-04-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C220- Liver cell carcinoma

Interventions

None listed

Sponsors

MOHAMED RELA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All Hepatocellular carcinoma patients who undergo resection or liver transplantation with a curative intent

Exclusion criteria

Exclusion criteria: 1. Non-Hepatocellular carcinoma liver tumours 2. Hepatocellular carcinoma patients who have undergone management with a non-curative intent (TACE/TARE/MWA etc.) 3. Patients not able to follow-up 4. Patients unwilling for the study

Design outcomes

Primary

MeasureTime frame
Post-Surgical Recurrence of Hepatocellular carcinoma Detected on CTC assay-correlating with image detected recurrenceTimepoint: Day 1, Day 7, Day 14, Day 30, 3 months, 6 months, 9 months, 12 months, 15 months, 18 months, 24 months—

Secondary

MeasureTime frame
1. Detect the lead-time between CTC rise and imaging 2. Prognosticate the risk of recurrence based on the first post-operative week delta-change in CTC after surgeryTimepoint: Day-1, Day-0(intraoperative), Day 1, Day 7, Day 14, Day 30, 3 months, 6 months, 9 months, 12 months, 15 months, 18 months, 24 months—

Countries

India

Contacts

Public ContactDR MADHUR PARDASANI

Dr Rela Institute and Meical Centre

mohamed.rela@gmail.com9884173583

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026